Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...

North Carolina's life sciences ecosystem is thriving, thanks in no small part to the leadership and innovation of women ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

VantAI today unveiled Neo-1, the world’s most advanced atomistic foundation model and the first to unify de novo molecular ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

February saw several changes on boards at biotechs, bringing a diverse wealth of experience to support these companies. Read ...

The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.